149 related articles for article (PubMed ID: 14677009)
1. Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate.
Vasireddy S; Talwalkar A; Miller H; Mehan R; Swinson DR
Clin Rheumatol; 2003 Dec; 22(6):376-80. PubMed ID: 14677009
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
[TBL] [Abstract][Full Text] [Related]
6. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
7. Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.
Gutteridge DH; Retallack RW; Ward LC; Price RI; Stewart GO; Stuckey BG; Prince RL; Kent GN; Bhagat CI; Thompson RI; Nicholson GC
Bone; 2003 Jan; 32(1):56-61. PubMed ID: 12584036
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C
Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
[TBL] [Abstract][Full Text] [Related]
10. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Ryan PJ; Gibson T; Fogelman I
J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
[TBL] [Abstract][Full Text] [Related]
11. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
Tucci JR; Bontha S
Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277
[TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
Grauer A; Klar B; Knaus J; Scharla SH; Ziegler R
Med Klin (Munich); 1996 Jan; 91(1):14-9. PubMed ID: 8839196
[TBL] [Abstract][Full Text] [Related]
13. Effect of multiple intravenous pamidronate courses in Paget's disease of bone.
Trombetti A; Arlot M; Thevenon J; Uebelhart B; Meunier PJ
Rev Rhum Engl Ed; 1999 Oct; 66(10):467-76. PubMed ID: 10567975
[TBL] [Abstract][Full Text] [Related]
14. The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study.
Bender T; Donáth J; Barna I; Gergely P; Poór G
Neuro Endocrinol Lett; 2006 Aug; 27(4):513-5. PubMed ID: 16891991
[TBL] [Abstract][Full Text] [Related]
15. Low back pain in Paget's disease of bone.
Altman RD; Brown M; Gargano F
Clin Orthop Relat Res; 1987 Apr; (217):152-61. PubMed ID: 2951047
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
[No Abstract] [Full Text] [Related]
17. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
Wilczek H
Cas Lek Cesk; 1997 Dec; 136(23):730-2. PubMed ID: 9476376
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate infusions for the treatment of Paget's disease of bone.
Mazieres B; Ahmed I; Moulinier L; Bon E; Cantagrel A; Laroche M
Rev Rhum Engl Ed; 1996 Jan; 63(1):36-43. PubMed ID: 9064108
[TBL] [Abstract][Full Text] [Related]
19. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment.
Laroche M; Delpech B; Bernard J; Constantin A; Mazières B
Calcif Tissue Int; 1999 Sep; 65(3):188-91. PubMed ID: 10441648
[TBL] [Abstract][Full Text] [Related]
20. High-dose pamidronate in the management of resistant Paget's disease.
Cundy T; Wattie D; King AR
Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
